PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 178 filers reported holding PTC THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 1.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,959,000 | +15.6% | 39,030 | -7.8% | 0.02% | +18.8% |
| Q2 2022 | $1,695,000 | -38.0% | 42,324 | -42.3% | 0.02% | -46.7% |
| Q1 2022 | $2,736,000 | -16.0% | 73,342 | -10.4% | 0.03% | -18.9% |
| Q4 2021 | $3,259,000 | +1.2% | 81,816 | -5.4% | 0.04% | +19.4% |
| Q3 2021 | $3,220,000 | -17.6% | 86,531 | -6.4% | 0.03% | -11.4% |
| Q2 2021 | $3,910,000 | -35.1% | 92,497 | -27.3% | 0.04% | -40.7% |
| Q1 2021 | $6,024,000 | -19.3% | 127,228 | +4.0% | 0.06% | -29.8% |
| Q4 2020 | $7,468,000 | +85.0% | 122,374 | +41.7% | 0.08% | +42.4% |
| Q3 2020 | $4,037,000 | -7.2% | 86,343 | +0.7% | 0.06% | +1.7% |
| Q2 2020 | $4,352,000 | -12.7% | 85,770 | -23.3% | 0.06% | -24.7% |
| Q1 2020 | $4,986,000 | -16.4% | 111,763 | -10.0% | 0.08% | +67.4% |
| Q4 2019 | $5,961,000 | +49.8% | 124,113 | +5.5% | 0.05% | +48.4% |
| Q3 2019 | $3,978,000 | -27.4% | 117,610 | -3.5% | 0.03% | -24.4% |
| Q2 2019 | $5,482,000 | +5.2% | 121,826 | -12.0% | 0.04% | +10.8% |
| Q1 2019 | $5,212,000 | +30.2% | 138,464 | +18.7% | 0.04% | +19.4% |
| Q4 2018 | $4,002,000 | +3.0% | 116,602 | +41.1% | 0.03% | +24.0% |
| Q3 2018 | $3,885,000 | +70.8% | 82,666 | +22.6% | 0.02% | +66.7% |
| Q2 2018 | $2,274,000 | +51.0% | 67,405 | +21.1% | 0.02% | +25.0% |
| Q1 2018 | $1,506,000 | +96.3% | 55,648 | +21.0% | 0.01% | +140.0% |
| Q4 2017 | $767,000 | -6.0% | 45,975 | +12.8% | 0.01% | -16.7% |
| Q3 2017 | $816,000 | +42.7% | 40,762 | +30.7% | 0.01% | +50.0% |
| Q2 2017 | $572,000 | +96.6% | 31,191 | +5.6% | 0.00% | +100.0% |
| Q1 2017 | $291,000 | -19.2% | 29,524 | -10.5% | 0.00% | -33.3% |
| Q4 2016 | $360,000 | -41.2% | 32,979 | -24.5% | 0.00% | -40.0% |
| Q3 2016 | $612,000 | +81.1% | 43,660 | -9.3% | 0.01% | +66.7% |
| Q2 2016 | $338,000 | +36.3% | 48,135 | +24.9% | 0.00% | 0.0% |
| Q1 2016 | $248,000 | -83.0% | 38,541 | -14.6% | 0.00% | -78.6% |
| Q4 2015 | $1,463,000 | -89.8% | 45,147 | -15.8% | 0.01% | -6.7% |
| Q3 2015 | $14,323,000 | +785.8% | 53,643 | +59.7% | 0.02% | +7.1% |
| Q2 2015 | $1,617,000 | +58.5% | 33,591 | +100.3% | 0.01% | +75.0% |
| Q1 2015 | $1,020,000 | – | 16,768 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Burrage Capital Management LLC | 161,083 | $9,831,000 | 7.49% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 333,000 | $20,323,000 | 5.55% |
| RTW INVESTMENTS, LP | 4,221,836 | $257,659,000 | 4.32% |
| GEORGE KAISER FAMILY FOUNDATION | 90,011 | $10,766,000 | 2.85% |
| SECTORAL ASSET MANAGEMENT INC | 603,978 | $36,861,000 | 2.60% |
| Redwood Investments, LLC | 364,837 | $22,266,000 | 1.90% |
| ARMISTICE CAPITAL, LLC | 716,000 | $43,697,000 | 1.49% |
| CM Management, LLC | 25,000 | $1,526,000 | 1.42% |
| Third Security, LLC | 237,015 | $14,465,000 | 1.32% |
| Sofinnova Investments, Inc. | 316,478 | $19,315,000 | 1.15% |